Wed, Apr 16, 2014, 5:49 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

RPC Inc. Message Board

diegodelaveg 3 posts  |  Last Activity: Mar 12, 2014 9:14 AM Member since: Jan 17, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • diegodelaveg by diegodelaveg Mar 12, 2014 9:14 AM Flag

    Teva is now touching a long term resistant limit ,it could swing back to the 40 lattitude.. May Copax patent exclusivity deadline could trigger this swing back to 40 or lower. Been a such dissapointing stock i would recommend precaution.

  • Reply to

    Phillip Frost

    by diegodelaveg Mar 6, 2014 9:41 AM
    diegodelaveg diegodelaveg Mar 7, 2014 6:14 AM Flag

    New Copaxone is pure bluff ,Momenta ,Gilead, Novartis will take over this market easily with oral treatments.Teva is highly dependent on Copaxone, 50 % of earnings come from that market glutted blockbuster drug ,the only one i can recall to be important for Teva. On the other hand Generics can be manufactured cheaper in India or China. The only hope for Teva short term is to reduce costs but the original plan devised by Ex-Ceo Jeremy Levin is now nowhere near. No clue for a new blockbuster and may-14 is too close now.

    Sentiment: Sell

  • diegodelaveg by diegodelaveg Mar 6, 2014 9:41 AM Flag

    has a long history of investment failures . Teva is about to lose its Copaxone patent in may 14. Wait for you at the 37-38 level. Soros is betting to a General Market correction his Teva position is just for Hedging.All the forementioned reason made me stay away from this stock.

    Sentiment: Sell

20.98+0.48(+2.34%)Apr 16 4:03 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.